DK474288D0 - Benzimidazolderivater og fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende benzimidazolderivaterne - Google Patents

Benzimidazolderivater og fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende benzimidazolderivaterne

Info

Publication number
DK474288D0
DK474288D0 DK474288A DK474288A DK474288D0 DK 474288 D0 DK474288 D0 DK 474288D0 DK 474288 A DK474288 A DK 474288A DK 474288 A DK474288 A DK 474288A DK 474288 D0 DK474288 D0 DK 474288D0
Authority
DK
Denmark
Prior art keywords
benzimidazold
derivatives
procedures
preparing
benzimidazold derivatives
Prior art date
Application number
DK474288A
Other languages
English (en)
Other versions
DK474288A (da
DK169701B1 (da
Inventor
Klaus Schoellkopf
Helmut Wachtel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK474288D0 publication Critical patent/DK474288D0/da
Publication of DK474288A publication Critical patent/DK474288A/da
Application granted granted Critical
Publication of DK169701B1 publication Critical patent/DK169701B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK474288A 1987-08-25 1988-08-25 Benzimidazolderivater og fremgangsmåder til fremstilling deraf samt lægemiddel indeholdende benzimidazolderivaterne DK169701B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3728695 1987-08-25
DE19873728695 DE3728695A1 (de) 1987-08-25 1987-08-25 Neue benzimidazol-derivate

Publications (3)

Publication Number Publication Date
DK474288D0 true DK474288D0 (da) 1988-08-25
DK474288A DK474288A (da) 1989-02-26
DK169701B1 DK169701B1 (da) 1995-01-16

Family

ID=6334659

Family Applications (1)

Application Number Title Priority Date Filing Date
DK474288A DK169701B1 (da) 1987-08-25 1988-08-25 Benzimidazolderivater og fremgangsmåder til fremstilling deraf samt lægemiddel indeholdende benzimidazolderivaterne

Country Status (17)

Country Link
US (1) US4925854A (da)
EP (1) EP0304789B1 (da)
JP (1) JP2818170B2 (da)
AT (1) ATE86982T1 (da)
AU (1) AU615939B2 (da)
CA (1) CA1330440C (da)
DD (1) DD274215A5 (da)
DE (2) DE3728695A1 (da)
DK (1) DK169701B1 (da)
ES (1) ES2054752T3 (da)
FI (1) FI99013C (da)
HU (1) HU201746B (da)
IE (1) IE63283B1 (da)
IL (1) IL87561A (da)
NO (1) NO170852C (da)
PT (1) PT88326B (da)
ZA (1) ZA886336B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
US5371102A (en) * 1992-03-11 1994-12-06 University Of Hawaii Compositions and methods of inhibiting thyroid activity
PE27997A1 (es) 1994-04-29 1997-09-20 Lilly Co Eli Antagonistas de receptores de taquicininas
US5565454A (en) * 1995-05-31 1996-10-15 Ergo Science, Incorporated Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
TW356468B (en) * 1995-09-15 1999-04-21 Astra Pharma Prod Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en) * 1995-12-23 1996-02-28 Astra Pharma Prod Pharmaceutically active compounds
WO2004032861A2 (en) * 2002-10-11 2004-04-22 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
MX346346B (es) 2011-12-16 2017-03-14 Colgate Palmolive Co Composiciones que cambian de color.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813409A (en) * 1972-07-31 1974-05-28 Squibb & Sons Inc Benzimidazolinone compounds
DE3042481A1 (de) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4367337A (en) * 1981-01-05 1983-01-04 The Sherwin-Williams Company Process for conversion of benzimidazolones to benzotriazoles
WO1986001204A1 (en) * 1984-08-15 1986-02-27 Schering Aktiengesellschaft New dopamine derivatives, process for their production, and their use as medicinal products
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones

Also Published As

Publication number Publication date
FI883930L (fi) 1989-02-26
ATE86982T1 (de) 1993-04-15
PT88326A (pt) 1989-06-30
IL87561A0 (en) 1989-01-31
IE63283B1 (en) 1995-04-05
FI99013B (fi) 1997-06-13
ZA886336B (en) 1989-04-26
HU201746B (en) 1990-12-28
DE3728695A1 (de) 1989-03-09
AU2149888A (en) 1989-03-02
DK474288A (da) 1989-02-26
CA1330440C (en) 1994-06-28
FI99013C (fi) 1997-09-25
NO170852B (no) 1992-09-07
NO883776L (no) 1989-02-27
ES2054752T3 (es) 1994-08-16
IE882552L (en) 1989-02-25
FI883930A0 (fi) 1988-08-25
EP0304789A3 (en) 1989-10-04
DK169701B1 (da) 1995-01-16
HUT49589A (en) 1989-10-30
NO883776D0 (no) 1988-08-24
AU615939B2 (en) 1991-10-17
JPS6468359A (en) 1989-03-14
JP2818170B2 (ja) 1998-10-30
IL87561A (en) 1993-02-21
DE3879322D1 (de) 1993-04-22
EP0304789B1 (de) 1993-03-17
DD274215A5 (de) 1989-12-13
PT88326B (pt) 1995-03-31
EP0304789A2 (de) 1989-03-01
US4925854A (en) 1990-05-15
NO170852C (no) 1992-12-16

Similar Documents

Publication Publication Date Title
DK154287A (da) Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne
NO884625D0 (no) N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel.
NO842977L (no) Nye insulinderivater, fremgangsmaate til deres fremstilling og deres anvendelse, samt farmasoeytiske midler for behandling av diabetes
DK111387D0 (da) Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
DK53285D0 (da) (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme
NO863765L (no) Arylmetylazoler og salter derav samt fremgangsmaate til fremstilling derav.
DK474288A (da) Benzimidazolderivater og fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende benzimidazolderivaterne
AR240924A1 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
NO885552D0 (no) Nye derivater av cykliske aminosyrer og fremgangsmaate for fremstilling derav.
NO881545D0 (no) Nye pyrrolidin-2-(1,3-dikarbonyl)-derivater, samt fremgangsmaate for fremstilling derav.
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
NO884110D0 (no) Nye aminosyreestere, samt fremgangsmaater for fremstilling derav.
NO893167D0 (no) Nye 6-fluor-3,5-dihydroksykarboksylsyrer og deres derivater samt fremgangsmaater for fremstilling derav.
NO870834D0 (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
DK291088D0 (da) Tetrehydrofuran- og tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater
NO159168C (no) Salter av n-oxiranmethan-n, n, n-trialkylammoniumderivater og deres anvendelse for impregnering av polyhydroxylerteeller polyaminerte polymerer.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
NO865004D0 (no) Nye 16,17-acetalsubstituerte pregnan-21-oinsyre-derivater og fremgangsmaate for deres fremstilling.
DK291188A (da) 5-methoxyalkylammonium-tetrahydrofuran- og -tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater
FI881075A0 (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
NO881554L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-((1,1-difenyl)-1-alkenyl)piperazin-derivater og farmasoeytisk aksepterbare salter av disse derivater.
DK160832C (da) Heterocycliske bornan-derivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne forbindelser
RO96949A2 (ro) Produs medicamentos pentru tratarea otitelor
NO894189D0 (no) 4-amino-3-acylkinolonderivater og deres anvendelse som inhibitorer av mavesyresekresjon.
IT8122172A0 (it) Procedimento per la preparazione di 1-(4-ammino-3,5-diclorofenil)-2-terzbutilammino etanolo e suoi sali.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed